Otis W Brawley

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Cancer screening in theory and in practice
    Otis W Brawley
    Georgia Cancer Center, Glenn Memorial Bldg, 69 Jesse Hill Jr Drive, Atlanta, GA 30303, USA
    J Clin Oncol 23:293-300. 2005
  2. ncbi Hormonal prevention of prostate cancer
    Otis W Brawley
    Professor of Medicine, Oncology and Epidemiology, The Winship Cancer Institute, Emory University, Atlanta, GA, USA
    Urol Oncol 21:67-72. 2003
  3. ncbi Prostate cancer screening: clinical applications and challenges
    Otis W Brawley
    Winship Cancer Institute, Emory University School of Medicine and Emory Rollins School of Public Health, 69 Jesse Hill Jr Drive, Atlanta, GA 30303, USA
    Urol Oncol 22:353-7. 2004
  4. ncbi Population categorization and cancer statistics
    Otis W Brawley
    Winship Cancer Institute Emory University, Atlanta, Georgia, USA
    Cancer Metastasis Rev 22:11-9. 2003
  5. ncbi Introduction: Cancer and health disparities
    Otis W Brawley
    Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
    Cancer Metastasis Rev 22:7-9. 2003
  6. ncbi Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population
    Sheryl G A Gabram
    Georgia Cancer Center for Excellence at Grady Health System, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Cancer 113:602-7. 2008
  7. ncbi Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
    Mary Jo Lund
    Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, USA
    Breast Cancer Res Treat 113:357-70. 2009
  8. ncbi Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening
    Robert A Smith
    Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
    CA Cancer J Clin 60:99-119. 2010
  9. ncbi Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening
    Robert A Smith
    Director of Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA, USA
    CA Cancer J Clin 61:8-30. 2011
  10. ncbi Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer
    Monica Rizzo
    Avon Comprehensive Breast Cancer Center at Grady, Emory University, Atlanta, Georgia, USA
    Cancer 115:3009-15. 2009

Detail Information

Publications47

  1. ncbi Cancer screening in theory and in practice
    Otis W Brawley
    Georgia Cancer Center, Glenn Memorial Bldg, 69 Jesse Hill Jr Drive, Atlanta, GA 30303, USA
    J Clin Oncol 23:293-300. 2005
    ..A screening test is done on asymptomatic individuals who receive the test principally because they are of the age or sex at risk for the cancer. A diagnostic test is done on an individual because of clinical suspicion of disease...
  2. ncbi Hormonal prevention of prostate cancer
    Otis W Brawley
    Professor of Medicine, Oncology and Epidemiology, The Winship Cancer Institute, Emory University, Atlanta, GA, USA
    Urol Oncol 21:67-72. 2003
    ..A placebo controlled randomized trial using finasteride, an inhibitor of 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone, is ongoing. The endpoint of this trial is reduction of prostate cancer incidence...
  3. ncbi Prostate cancer screening: clinical applications and challenges
    Otis W Brawley
    Winship Cancer Institute, Emory University School of Medicine and Emory Rollins School of Public Health, 69 Jesse Hill Jr Drive, Atlanta, GA 30303, USA
    Urol Oncol 22:353-7. 2004
    ....
  4. ncbi Population categorization and cancer statistics
    Otis W Brawley
    Winship Cancer Institute Emory University, Atlanta, Georgia, USA
    Cancer Metastasis Rev 22:11-9. 2003
    ..While a specific gene or series of genes can be conserved within a relatively closed population, genetic variation within a given population or race is significant...
  5. ncbi Introduction: Cancer and health disparities
    Otis W Brawley
    Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
    Cancer Metastasis Rev 22:7-9. 2003
  6. ncbi Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population
    Sheryl G A Gabram
    Georgia Cancer Center for Excellence at Grady Health System, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Cancer 113:602-7. 2008
    ..They then assessed the effectiveness of these outreach initiatives and internal patient navigation on stage of diagnosis...
  7. ncbi Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
    Mary Jo Lund
    Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322, USA
    Breast Cancer Res Treat 113:357-70. 2009
    ..This study examines association of the ER/PR/HER2 subtypes with race and breast cancer survival...
  8. ncbi Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening
    Robert A Smith
    Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
    CA Cancer J Clin 60:99-119. 2010
    ....
  9. ncbi Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening
    Robert A Smith
    Director of Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA, USA
    CA Cancer J Clin 61:8-30. 2011
    ..The latest data on the utilization of cancer screening from the National Health Interview Survey is described, as well as several recent reports on the role of health care professionals in adult utilization of cancer screening...
  10. ncbi Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer
    Monica Rizzo
    Avon Comprehensive Breast Cancer Center at Grady, Emory University, Atlanta, Georgia, USA
    Cancer 115:3009-15. 2009
    ..The aim of this study was to correlate age, receptor status, nuclear grade, and differences in treatment modalities for stage III breast cancer in an inner-city hospital serving a large AA population...
  11. ncbi Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening
    Robert A Smith
    Cancer Control Science Department, American Cancer Society, Atlanta, GA 30303, USA
    CA Cancer J Clin 59:27-41. 2009
    ....
  12. ncbi Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology
    Timothy V Johnson
    Department of Urology, School of Medicine, Emory University, Atlanta, GA 30322, USA
    Psychooncology 21:351-6. 2012
    ..Therefore, we sought to characterize the distribution of suicides in order to potentially identify a clinically important window of peak suicide risk...
  13. ncbi A black-white comparison of the quality of stage-specific colon cancer treatment
    Jamillah Berry
    Prevention Research Center, Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia 30310 1495, USA
    Cancer 116:713-22. 2010
    ..However, an Institute of Medicine report found that blacks received lower quality care than whites after controlling for health insurance, income, and disease severity...
  14. ncbi Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis
    Ashesh B Jani
    Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
    Am J Clin Oncol 31:375-8. 2008
    ..The objective of this investigation was to use the Surveillance, Epidemiology, and End Results (SEER) registry to examine time trends in age and grade...
  15. ncbi Screening for prostate cancer
    Otis W Brawley
    American Cancer Society, Atlanta, GA, USA
    CA Cancer J Clin 59:264-73. 2009
    ..Men undergoing screening for prostate cancer may reduce their risk of prostate cancer with finasteride...
  16. ncbi Racial disparities in colorectal cancer
    John Kauh
    Department of Hematology and Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia, USA
    Curr Probl Cancer 31:123-33. 2007
  17. ncbi Prostate cancer epidemiology in the United States
    Otis W Brawley
    Department of Hematology and Medical Oncology, Emory University, American Cancer Society, Atlanta, GA, USA
    World J Urol 30:195-200. 2012
    ..It is the most commonly diagnosed non-skin cancer and the second leading cause of cancer death. The American Cancer Society estimates that in 2011, 240,890 men were diagnosed with prostate cancer and 33,720 men died of it...
  18. ncbi Myeloma and race: a review of the literature
    Michael Benjamin
    Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
    Cancer Metastasis Rev 22:87-93. 2003
    ..Factors such as socioeconomic status, dietary preferences, vitamin intake, alcohol and tobacco use, either lack a consensus finding, or may not play a role in explaining the increased myeloma morbidity and mortality in blacks...
  19. ncbi Toward a better understanding of race and cancer
    Otis W Brawley
    Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia 30303, USA
    Clin Cancer Res 16:5920-2. 2010
    ..Advances in immunohistochemistry and the appreciation of breast cancer subtypes are enabling investigators to study the distribution of these subtypes among populations...
  20. ncbi Examining racial differences in diffuse large B-cell lymphoma presentation and survival
    Christopher R Flowers
    Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
    Leuk Lymphoma 54:268-76. 2013
    ..61, p = 0.01). Future studies should examine biological differences that may underlie the observed racial differences in presentation and outcome...
  21. ncbi Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States
    Christopher R Flowers
    Department of Hematology Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA
    Cancer Epidemiol Biomarkers Prev 21:1520-30. 2012
    ..In 2002, randomized trials changed this standard by showing that adding rituximab immunotherapy to CHOP improved survival. However, how these results influenced chemoimmunotherapy adoption in clinical practice remains unclear...
  22. ncbi The American Cancer Society and the American Health Care System
    Otis W Brawley
    F A C P, American Cancer Society, Atlanta, Georgia 30303, USA
    Oncologist 16:920-5. 2011
    ..We are committed proponents of the rational, evidence-based use of health care to avoid the wasteful and inefficient rationing of health care...
  23. ncbi Prostate cancer in black and white Americans
    Sreekanth Reddy
    Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
    Cancer Metastasis Rev 22:83-6. 2003
    ..Several studies show that there are racial differences in patterns of care in the US and it has been hypothesized that this contributes to some of the racial disparity in survival after diagnosis...
  24. ncbi Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program
    Timothy V Johnson
    Department of Urology, School of Medicine, Emory University, Atlanta, GA 30322, USA
    Cancer 116:2960-6. 2010
    ..Therefore, they assessed the frequency of inguinal lymphadenectomy and the impact of dissection extent on survival using the Surveillance, Epidemiology, and End Results (SEER) database...
  25. ncbi Cancer screening
    Otis W Brawley
    Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
    Semin Oncol 31:47-53. 2004
    ..Many available screening tests have tremendous potential in terms of benefit, but have yet to be fully assessed. At the minimum, patients should be informed of what is known, what is not known, and what is believed about these tests...
  26. ncbi Oropharyngeal cancer, race, and the human papillomavirus
    Otis W Brawley
    American Cancer Society, Atlanta, GA 30303, USA
    Cancer Prev Res (Phila) 2:769-72. 2009
    ..This discussion is expanded to a more general consideration of biological and nonbiological (e.g., socioeconomic and cultural) factors affecting racial disparities in disease...
  27. ncbi Prostate cancer and race
    Otis W Brawley
    Department of Hematology and Oncology, Emory School of Medicine, Emory University, Atlanta, Georgia, USA
    Curr Probl Cancer 31:211-25. 2007
  28. ncbi Racial differences in the incidence and outcomes for patients with hematological malignancies
    Christopher R Flowers
    Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
    Curr Probl Cancer 31:182-201. 2007
  29. ncbi National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease
    Otis W Brawley
    American Cancer Society, 250 Williams Street, Atlanta, GA 30303, USA
    Ann Intern Med 148:932-8. 2008
  30. ncbi Racial disparities in lung cancer
    Mitchel Berger
    Emory University, Atlanta, Georgia, USA
    Curr Probl Cancer 31:202-10. 2007
  31. ncbi Cancer and disparities in health: perspectives on health statistics and research questions
    Otis W Brawley
    American Cancer Society, Atlanta, Georgia 30303, USA
    Cancer 113:1744-54. 2008
  32. ncbi High prevalence of triple-negative tumors in an urban cancer center
    Mary Jo B Lund
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA
    Cancer 113:608-15. 2008
    ..In the current study, the authors investigated breast cancer subgroups among patients in an urban cancer center serving a multiracial, low socioeconomic population...
  33. ncbi Nonmedical factors in treatment selection
    Otis W Brawley
    Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Road, NE, Suite B4100, Atlanta, GA 30322, USA
    Urol Clin North Am 30:331-5. 2003
    ..These factors, along with the absence of a clearly superior therapy, account, at least in part, for the tremendous variance in patterns of care by age, geography, race and education...
  34. ncbi Race and disparities in health
    Otis W Brawley
    Hematology and Oncology, Emory School of Medicine, Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
    Curr Probl Cancer 31:114-22. 2007
  35. ncbi Chemoprevention in prostate cancer
    Vasileios Assikis
    Winship Cancer Institute at Emory University, Atlanta, GA, USA
    Curr Probl Cancer 28:218-30. 2004
  36. ncbi Some perspective on black-white cancer statistics
    Otis W Brawley
    CA Cancer J Clin 52:322-5. 2002
  37. ncbi Survival of blacks and whites after a cancer diagnosis
    Peter B Bach
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    JAMA 287:2106-13. 2002
    ..Differences in treatment, stage at presentation, and mortality from other diseases should represent the primary targets of research and interventions designed to reduce disparities in cancer outcomes...
  38. ncbi Informed consent for prostate-specific antigen-based screening
    Otis W Brawley
    Urology 61:10-2. 2003
  39. ncbi Are racial and ethnic minorities less willing to participate in health research?
    David Wendler
    Department of Clinical Bioethics, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
    PLoS Med 3:e19. 2006
    ..It is widely claimed that racial and ethnic minorities, especially in the US, are less willing than non-minority individuals to participate in health research. Yet, there is a paucity of empirical data to substantiate this claim...
  40. ncbi Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment
    Otis W Brawley
    J Clin Oncol 24:332-3. 2006
  41. ncbi The worldwide epidemiology of prostate cancer: perspectives from autopsy studies
    Gabriel P Haas
    Department of Urology, SUNY Upstate Medical University, Syracuse, New York 13210, USA
    Can J Urol 15:3866-71. 2008
    ..Prostate cancer is the most frequently diagnosed non-skin cancer in the United States and the third leading cause of cancer deaths. International trends in the incidence, mortality and prevalence of prostate cancer are assessed...
  42. ncbi Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database
    William F Anderson
    NCI Division of Cancer Prevention, EPN, Bethesda, MD 20892 7317, USA
    Breast Cancer Res Treat 76:27-36. 2002
    ..Researchers question whether estrogen receptor alpha-negative (ERN) and -positive (ERP) represent different stages of one disease or different breast cancer types...
  43. ncbi Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004
    Shamim M Baker
    Urology 65:1259-62. 2005
  44. ncbi New ACS chief medical officer. Interview by Carrie Printz
    Otis W Brawley
    Cancer 113:1499. 2008
  45. ncbi Colorectal carcinoma in black and white race
    William F Anderson
    National Cancer Institute/Division of Cancer Prevention/Gastrointestinal Cancer and Other Cancers Research Group, Bethesda, Maryland, USA
    Cancer Metastasis Rev 22:67-82. 2003
    ..Racial variations demonstrate the need for a more comprehensive understanding of colorectal carcinogenesis, epidemiology, and colorectal screening patterns for low- and high-risk populations...
  46. ncbi Disaggregating the effects of race and poverty on breast cancer outcomes
    Otis W Brawley
    J Natl Cancer Inst 94:471-3. 2002
  47. ncbi The study of accrual to clinical trials: can we learn from studying who enters our studies?
    Otis W Brawley
    J Clin Oncol 22:2039-40. 2004